| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Transaction costs fees charges | 6 | 6 | 6 | 6 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| 02MICRO | 2008-12 | Purchase | 2023-03 |
02MICRO |
19,800 | 8,122 | 0 | 0 | ||
| ZTO | 2016-10 | Purchase | 2023-04 |
ZTO |
2,859 | 1,950 | 0 | 0 | ||
| STORE CAP | 2014-11 | Purchase | 2023-02 |
STORE CAP |
3,225 | 1,747 | 0 | 0 | ||
| ROCKET | 2015-02 | Purchase | 2023-04 |
ROCKET |
412 | 600 | 0 | 0 | ||
| OBSEVA | 2017-01 | Purchase | 2023-04 |
OBSEVA |
9 | 1,500 | 0 | 0 | ||
| ELANCO | 2013-06 | Purchase | 2023-04 |
ELANCO |
126 | 567 | 0 | 0 | ||
| EVOFEM | 2014-11 | Purchase | 2023-04 |
EVOFEM |
0 | 1,260 | 0 | 0 | ||
| KALVISTA | 2015-04 | Purchase | 2023-04 |
KALVISTA |
166 | 1,470 | 0 | 0 | ||
| LARIMAR | 2014-06 | Purchase | 2023-04 |
LARIMAR |
36 | 1,536 | 0 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| UBS | 394,099 | 394,099 |
| ATENTO | 1 | 1 |
| YANDEX | 0 | 0 |
| Cerence | 1,809 | 1,809 |
| Fate Therapeutics | 1,496 | 1,496 |
| Fidelity National Info Services | 11,053 | 11,053 |
| FIRST HAWAIIAN | 2,286 | 2,286 |
| LAUREATE ED | 1,371 | 1,371 |
| MPLX LP | 1,248 | 1,248 |
| MCKESSON | 62,965 | 62,965 |
| NGL ENERGY PARTNERS | 21,723 | 21,723 |
| OCCIDENTAL PETE | 31,348 | 31,348 |
| TEVA PHARMA | 6,880 | 6,880 |
| XBIOTECH | 536 | 536 |
| LADDER CAP | 1,289 | 1,289 |
| OCCIDENTAL PETE WTS | 2,530 | 2,530 |
| OMEGA HEALTHCARE | 2,759 | 2,759 |
| PARAMOUNT GROUP | 517 | 517 |
| Futu Holdings | 5,463 | 5,463 |
| Tesla | 22,363 | 22,363 |
| Workiva | 10,153 | 10,153 |
| S S & C Tech | 15,278 | 15,278 |
| SEA Limited Ads | 4,050 | 4,050 |
| Zillow A | 2,496 | 2,496 |
| Zillow C | 5,092 | 5,092 |
| Keros Thera | 7,952 | 7,952 |
| Profound Med | 4,245 | 4,245 |
| Star Equity Holdings | 1,045 | 1,045 |
| Pinduoduo | 14,631 | 14,631 |
| Emeren Group Ltd Spons Ads | 2,097 | 2,097 |
| Obseva | 0 | 0 |
| Elanco | 0 | 0 |
| Evofem | 0 | 0 |
| Kalvista | 0 | 0 |
| Larimar | 0 | 0 |
| Rocket | 0 | 0 |
| ZTO | 0 | 0 |
| Cyrusome | 0 | 0 |
| Store Corp | 0 | 0 |
| O2Micro | 0 | 0 |
| Category/ Item | Cost/Other Basis | Accumulated Depreciation | Book Value | End of Year Fair Market Value |
|---|---|---|---|---|
| Land | 0 | 0 | 0 | 0 |
| Buildings | 0 | 0 | 0 | 0 |
| Leasehold improvements | 0 | 0 | 0 | 0 |
| Equipment | 0 | 0 | 0 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Fingerprinting fee | 24 | 24 | 24 | 24 |
| Telecom | 158 | 158 | 158 | 158 |
| Credit card fees | 108 | 108 | 108 | 108 |
| Description | Amount |
|---|---|
| Increase in Value of Securities | 191,297 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| Margin Loan | 81,416 | 67,195 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Paid to Tax 990 for filing of 2022 return | 151 | 151 | 151 | 151 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Foreign Tax Paid | 1,226 | 1,226 | 1,226 | 1,226 |
| Tax paid to IRS for 2022 | 297 | 297 | 297 | 297 |